Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 295
Selected: 0
NCT IDTitle
NCT01282697Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors
NCT00349505Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma
NCT02246244Randomized, Double Blind, Efficacy Study of Escitalopram in ENT Cancer Patients Suffering From Emotional Distress
NCT02517892A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents
NCT03614936Study of a Simplified Geriatric Evaluation Performed by Oncologists Prior to Cancer Treatment by Radiotherapy or Chemotherapy in Subjects Aged 70 Years or Older With Inoperable Squamous Cell Cancer of the Head and Neck
NCT02025881Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma
NCT07159451A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer
NCT04826445USE OF 18FDG PET-CT TO PREDICT THE RESPONSE OF MANDIBULAR OSTEORADIONECROSIS TO THE PENTOCLO PROTOCOL WITH DOCUMENTED ANTIBIOTHERAPY
NCT07001618Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
NCT02105168Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT04826198Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP Inhibitors Since at Least 6 Months
NCT02666625Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank
NCT06439888Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer
NCT03351296Two Chemotherapy Regimens Plus or Minus Bevacizumab
NCT07754006Preliminary Clinical Feasibility Study of a Medical Device Enabling Brain Access Using Microbubble-Enhanced Sonication
NCT02008734Randomized Phase II Study to Assess PD 0332991 in Breast Cancer
NCT06479057PROACT is a Prospective Master Protocol for a Cohort Study Focused on Evaluating the Implementation of Integrated Proactive Supportive Care Pathways at Gustave Roussy
NCT01864772Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC
NCT05912075Preoperative Radiotherapy And ASTX660 in Rectum Cancer
NCT02217956Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma
NCT00180882LMBA02 Protocol for Patients With a Burkitt Lymphoma
NCT04976556Breast Cancer Detection in Breast Surgical Specimens With the Histolog Scanner, Slide-free Confocal Microscope
NCT07471425Survival Without Persistent Limiting Toxicity: Real Life Prospective Cohort of Advanced Neuroendocrine Tumor
NCT02230176Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II
NCT02856425Trial Of Pembrolizumab And Nintedanib
NCT04267146Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma
NCT00162669Bevacizumab in Advanced Hepatocellular Carcinoma
NCT00181025Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle
NCT03609112Neurocognitive Risks in Children With Solid Tumors
NCT00410683Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery
NCT00346645A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer
NCT00418327Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma
NCT03010124Prognostic and Predictive Biomarkers in Ovarian Cancers
NCT06787118Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer
NCT04221035High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT05705791Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma
NCT01834950Identification of Early Markers of Response and Resistance to Trastuzumab
NCT03612791Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab
NCT00180947Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse
NCT01167530Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer
NCT04775121Classical Monocyte Kinetics in Chronic Myelomonocytic Leukemia
NCT01516580Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients
NCT02994576Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer
NCT04304924Motivating to Exercise and Diet, and Educating to Healthy Behaviors After Breast Cancer
NCT04826432Pasireotide to Reduce Clinically Relevant Digestive Leakage After Complete Cytoreductive Surgery (CRS) Plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis
NCT05119010A Pilot Study Evaluating a Ketogenic Diet Concomitant to Nivolumab and Ipilimumab in Patients With Metastatic Renal Cell Carcinoma
NCT03314324A Study of Patient Preference Between ODM-201 and Enzalutamide in Men With Metastatic Castrate-resistant Prostate Cancer
NCT02369757Patients Navigator for Organized Colorectal Cancer Screening
NCT01486251Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer
NCT00162812Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin